Skip to main content
Article thumbnail
Location of Repository

Exacerbations, health status and sibling pair comparisons in severe Alpha-1-Antitrypsin Deficiency

By Michelle Needham


Alpha-1-Antitrypsin Deficiency (AATD) is a risk factor for the development of early-onset emphysema and airflow obstruction. The current work defines exacerbations, lung function and health status in these patients including sibling pairs. Exacerbations occur commonly in AATD and are associated with worse health status. Exacerbations were associated with a decline in the gas transfer of the lung over time, but show no relationship to changes in forced expiratory volume in one second (FEV1). However, despite lung function decline, patients do not show a progressive loss in health status. Index patients have worse lung function and health status and more emphysema than non-index siblings. These differences are not solely explained by smoking or ascertainment. Although FEV1 values differ between sibling pairs, gas transfer does show significant correlation. Thus disease phenotype may also be influenced by other genetic modifiers. These results provide a firm basis upon which to design, power and implement trials of interventions that may reduce exacerbations and improve health status in patients. Furthermore sibling pairs, particularly those with discordant disease or concordant parenchymal disease, are an ideal group to further investigate the contribution of other genes in the development of COPD or its phenotype in AATD patients

Topics: RC Internal medicine
Year: 2007
OAI identifier:

Suggested articles


  1. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. doi
  2. Acute infective exacerbations of chronic bronchitis.
  3. (1997). Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur.Respir.J. doi
  4. (1990). Alpha-1-antitrypsin deficiency in a large sibship. Respiration doi
  5. alpha1-Antitrypsin deficiency in nonsmokers.
  6. American Thoracic Society, European Respiratory Society. Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency. doi
  7. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
  8. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin.
  9. Physical mapping of four serpin genes: alpha 1-antitrypsin, alpha 1-antichymotrypsin, corticosteroid-binding globulin, and protein C inhibitor, within a 280-kb region on chromosome I4q32.1.
  10. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.